John Lee
2021 - Decibel Therapeutics
In 2021, John Lee earned a total compensation of $816K as Executive Vice President, Chief Development Officer at Decibel Therapeutics.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Non-Equity Incentive Plan | $172,240 |
| Salary | $430,677 |
| Other | $13,188 |
| Total | $816,035 |
Lee received $430.7K in salary, accounting for 53% of the total pay in 2021.
Lee also received $200K in bonus, $172.2K in non-equity incentive plan and $13.2K in other compensation.
Rankings
In 2021, John Lee's compensation ranked 9,428th out of 12,412 executives tracked by ExecPay. In other words, Lee earned more than 24.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,428 out of 12,412 | 24th |
Division Manufacturing | 4,177 out of 5,498 | 24th |
Major group Chemicals And Allied Products | 1,849 out of 2,374 | 22nd |
Industry group Drugs | 1,641 out of 2,095 | 22nd |
Industry Pharmaceutical Preparations | 1,219 out of 1,542 | 21st |
Source: SEC filing on April 28, 2023.
Lee's colleagues
We found three more compensation records of executives who worked with John Lee at Decibel Therapeutics in 2021.
News
Marathon Patent Group CFO Hugh Gallagher receives $4.8M in 2022
June 23, 2023
Decibel Therapeutics CEO Laurence Reid's 2022 pay jumps 54% to $1.2M
April 28, 2023
PhaseBio Pharmaceuticals CEO Jonathan Mow's 2021 pay slips 13% to $1.5M
April 22, 2022
PhaseBio Pharmaceuticals CEO Jonathan Mow's 2019 pay jumps 102% to $1.2M
April 24, 2020
PhaseBio Pharmaceuticals CEO Jonathan Mow's 2018 pay jumps 37% to $596K
April 5, 2019